Every year in the U.S, over 10 million patients are affected by the leading cause of preventable hospital death known as Deep Vein Thrombosis, or DVT. Over 100,000 deaths per year are associated to hospital acquired DVTs, as well as over half a billion dollars in spending nationally on ineffective mechanical prophylaxis treatments. The FlexSpark DVT prevention device uses a wireless on-leg electrical muscle stimulation system that makes compliance the priority – allowing for speedier recoveries and better patient outcomes.
Why Choose Us?
Our device is a wireless on-leg electrical muscle stimulator that makes compliance the priority. This improves patient outcomes, leading to decreased hospitalization and associated costs. The FlexSpark system allows for a better user experience:
How It Works
Our Partners and Supporters
Contact Our Team
20 South Dudley St, Suite 100
Memphis, TN 38103
FlexSpark Inc. is not offering for sale any medical device at this time.
FlexSpark “X” is not FDA cleared